163 related articles for article (PubMed ID: 2150974)
1. Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats.
Galinsky RE; Eshima D; Hansen L; Greene J; Dillehay D; Taylor A
Mech Ageing Dev; 1990 Dec; 56(3):209-22. PubMed ID: 2150974
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
3. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
4. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
5. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
7. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent enzymuria, proteinuria and changes in renal blood flow and glomerular filtration rate in rats.
Casadevall G; Piera C; Setoain J; Queralt J
Mech Ageing Dev; 1995 Jul; 82(1):51-60. PubMed ID: 7475356
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicity.
Taylor A; Greene J; Eshima D; Dillehay D
Contrib Nephrol; 1990; 79():21-3. PubMed ID: 2146084
[No Abstract] [Full Text] [Related]
11. Glomerular filtration and tubular secretion of MAG-3 in the rat kidney.
Müller-Suur R; Müller-Suur C
J Nucl Med; 1989 Dec; 30(12):1986-91. PubMed ID: 2531220
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.
Rehling M; Frøkiaer J; Poulsen EU; Marqversen J; Nielsen BV; Bacher T
Clin Physiol; 1995 Jan; 15(1):57-71. PubMed ID: 7712693
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MAG3: dynamic studies in patients with renal disease.
Schaap GH; Alferink TH; de Jong RB; Oe PL; Roos JC; Donker AJ
Eur J Nucl Med; 1988; 14(1):28-31. PubMed ID: 2968259
[TBL] [Abstract][Full Text] [Related]
14. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
[TBL] [Abstract][Full Text] [Related]
15. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
Kengen RA; Meijer S; Beekhuis H; Piers DA
J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
Fritzberg AR; Kasina S; Eshima D; Johnson DL
J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
Eshima D; Greene J; Taylor A
Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
[No Abstract] [Full Text] [Related]
19. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
[TBL] [Abstract][Full Text] [Related]
20. Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine.
Gates GF
Clin Nucl Med; 2004 Apr; 29(4):231-7. PubMed ID: 15096969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]